Risk factors for incident nonmedical prescription opioid use and abuse and dependence: Results from a longitudinal nationally representative sample

Drug and Alcohol Dependence

Volumn 132, Issue 1-2, 2013, Pages 107-113

  Katz, Cara ^a   El Gabalawy, Renée ^a   Keyes, Katherine M ^b   Martins, Silvia S ^b   Sareen, Jitender ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Comorbidity; Epidemiology; NESARC; NMPOU; Nonmedical prescription opioid use; Opiates; Opioids; Risk factors

Indexed keywords

OPIATE;

ARTERIOSCLEROSIS; ARTHRITIS; ARTICLE; CARDIOVASCULAR DISEASE; COMORBIDITY; CONTROLLED STUDY; DRUG ABUSE; DSM-IV; FEMALE; HEALTH STATUS; HUMAN; HYPERTENSION; INTERVIEW; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MENTAL HEALTH; MOOD DISORDER; NONMEDICAL PRESCRIPTION OPIOID USE; OPIATE ADDICTION; PERSONALITY DISORDER; PRESCRIPTION; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; SELF REPORT; SEX DIFFERENCE; SUBSTANCE ABUSE;

COMORBIDITY; EPIDEMIOLOGY; NESARC; NMPOU; NONMEDICAL PRESCRIPTION OPIOID USE; OPIATES; OPIOIDS; RISK FACTORS;

ADOLESCENT; ADULT; AGE FACTORS; COMORBIDITY; DATA INTERPRETATION, STATISTICAL; DIAGNOSIS, DUAL (PSYCHIATRY); DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; EDUCATIONAL STATUS; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MENTAL DISORDERS; MIDDLE AGED; OPIOID-RELATED DISORDERS; PRESCRIPTION DRUG DIVERSION; RISK FACTORS; SEX FACTORS; SOCIOECONOMIC FACTORS; UNITED STATES; YOUNG ADULT;

EID: 84881665326     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2013.01.010     Document Type: Article

References (46)

1. Albert S., Brason F.W., Sanford C.K., Dasgupta N., Graham J., Lovette B. Project Lazarus: community-based overdose prevention in rural North Carolina. Planta Med. 2011, 12(Suppl. 2):S77-S85.
2. Atluri S., Akbik H., Sudarshan G. Prevention of opioid abuse in chronic non-cancer pain:an algorithmic, evidence based approach. Pain Physician 2012, 15:ES177-ES189.
3. Baumeister H., Kriston L., Bengel J., Harter M. High agreement of self-report and physician-diagnosed somatic conditions yields limited bias in examining mental-physical comorbidity. J. Clin. Epidemiol. 2010, 63:558-565.
4. Becker W.C., Sullivan L.E., Tetrault J.M., Desai R.A., Fiellin D.A. Non-medical use, abuse and dependence on prescription opioids among U.S. adults:psychiatric, medical and substance use correlates. Drug Alcohol Depend. 2008, 94:38-47.
5. Bohnert A.S., Valenstein M., Bair M.J., Ganoczy D., McCarthy J.F., Ilgen M.A., Blow F.C. Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA 2011, 305:1315-1321.
6. Boyer E.W., Wines J.D. Impact of Internet pharmacy regulation on opioid analgesic availability. J. Stud. Alcohol Drugs 2008, 69:703-708.
7. Carise D., Dugosh K.L., McLellan A.T., Camilleri A., Woody G.E., Lynch K.G. Prescription OxyContin abuse among patients entering addiction treatment. Am. J. Psychiatr. 2007, 164:1750-1756.
8. Centers for Disease Control and Prevention Community-based opioid overdose prevention programs providing naloxone - United States. MMWR Morb. Mortal. Wkly. Rep. 2012, 61:101-105.
9. Centers for Disease Control Prevention Vital signs: overdoses of prescription opioid pain relievers - United States, 1999-2008. MMWR 2011, 60:1487-1492.
10. Chatterji S., Saunders J.B., Vrasti R., Grant B.F., Hasin D., Mager D. Reliability of the alcohol and drug modules of the alcohol use disorder and associated disabilities interview schedule - alcohol/drug-revised (AUDADIS-ADR): an international comparison. Drug Alcohol Depend. 1997, 47:171-185.
11. Chou R., Fanciullo G.J., Fine P.G., Adler J.A., Ballantyne J.C., Davies P., Donovan M.I., Fishbain D.A., Foley K.M., Fudin J., Gilson A.M., Kelter A., Mauskop A., O'Connor P.G., Passik S.D., Pasternak G.W., Portenoy R.K., Rich B.A., Roberts R.G., Todd K.H., Miaskowski C. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J. Pain 2009, 10:113-130.
12. Cicero T.J., Lynskey M., Todorov A., Inciardi J.A., Surratt H.L. Co-morbid pain and psychopathology in males and females admitted to treatment for opioid analgesic abuse. Pain 2008, 139:127-135.
13. Cicero T.J., Shores C.N., Paradis A.G., Ellis M.S. Source of drugs for prescription opioid analgesic abusers: a role for the Internet?. Pain Med. 2008, 9:718-723.
14. Compton W.M., Volkow N.D. Major increases in opioid analgesic abuse in the United States: concerns and strategies. Drug. Alcohol Depend. 2006, 81:103-107.
15. Edlund M.J., Steffick D., Hudson T., Harris K.M., Sullivan M. Risk factors for clinically recognized opioid abuse and dependence among veterans using opioids for chronic non-cancer pain. Pain 2007, 129:355-362.
16. Edwards, W.S., Winn, D.M., Collins, J.G., National Health Interview Survey (U.S.), National Center for Health Statistics (U. S.), 1996. Evaluation of 2-week doctor visit reporting in the National Health Interview Survey. U.S. Dept. of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Center for Health Statistics, Hyattsville, MD.
17. El-Gabalawy R., Katz L.Y., Sareen J. Comorbidity and associated severity of borderline personality disorder and physical health conditions in a nationally representative sample. Psychosom. Med. 2010, 72:641-647.
18. Fenton M.C., Keyes K., Geier T., Greenstein E., Skodol A., Krueger B., Grant B.F., Hasin D.S. Psychiatric comorbidity and the persistence of drug use disorders in the United States. Addiction 2012, 107:599-609.
19. Gilson A.M., Ryan K.M., Joranson D.E., Dahl J.L. A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997-2002. J. Pain Symptom Manag. 2004, 28:176-188.
20. Grant B.F., Dawson D.A., Stinson F.S., Chou P.S., Kay W., Pickering R. The alcohol use disorder and associated disabilities interview schedule-IV (AUDADIS-IV): reliability of alcohol consumption, tobacco use, family history of depression and psychiatric diagnostic modules in a general population sample. Drug Alcohol Depend. 2003, 71:7-16.
21. Grant B.F., Stinson F.S., Dawson D.A., Chou S.P., Dufour M.C., Compton W., Pickering R.P., Kaplan K. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National epidemiologic survey on alcohol and related conditions. Arch. Gen. Psychiatr. 2004, 61:807-816.
22. Hasin D., Carpenter K.M., McCloud S., Smith M., Grant B.F. The alcohol use disorder and associated disabilities interview schedule (AUDADIS): reliability of alcohol and drug modules in a clinical sample. Drug Alcohol Depend. 1997, 44:133-141.
23. Havens J.R., Stoops W.W., Leukefeld C.G., Garrity T.F., Carlson R.G., Falck R., Wang J., Booth B.M. Prescription opiate misuse among rural stimulant users in a multistate community-based study. Am. J. Drug Alcohol Abuse 2009, 35:18-23.
24. Huang B., Dawson D.A., Stinson F.S., Hasin D.S., Ruan W.J., Saha T.D., Smith S.M., Goldstein R.B., Grant B.F. Prevalence, correlates, and comorbidity of nonmedical prescription drug use and drug use disorders in the United States: results of the National epidemiologic survey on alcohol and related conditions. J. Clin. Psychiatr. 2006, 67:1062-1073.
25. Inciardi J.A., Surratt H.L., Cicero T.J., Kurtz S.P., Martin S.S., Parrino M.W. The "black box" of prescription drug diversion. J. Addict. Dis. 2009, 28:332-347.
26. Ives T.J., Chelminski P.R., Hammett-Stabler C.A., Malone R.M., Perhac J.S., Potisek N.M., Shilliday B.B., DeWalt D.A., Pignone M.P. Predictors of opioid misuse in patients with chronic pain: a prospective cohort study. BMC Health Serv. Res. 2006, 6:46.
27. Kessler R.C., Wittchen H.U., Abelson J.M., McGonagle K., Schwarz M., Kendler K.S., Knauper B., Zhao S. Methodological studies of the composite international diagnostic interview (CIDI) in the US national comorbidity survey (NCS). Int. J. Methods Psychiatr. Res. 1998, 7:33-55.
28. Kinley, D.J., Lowry, H., Jacobi, F., Jassel, D., Katz, C., Sareen, J., 2012. The Relationship between anxiety disorders and physician diagnosed metabolic conditions: results from a Nationally representative survey. Anxiety Disorders Association of America Arlington, Virginia, USA.
29. Labianca R., Sarzi-Puttini P., Zuccaro S.M., Cherubino P., Vellucci R., Fornasari D. Adverse effects associated with non-opioid and opioid treatment in patients with chronic pain. Clin. Drug Investig. 2012, 32(Suppl. 1):53-63.
30. Lawrence D., Kisely S., Pais J. The epidemiology of excess mortality in people with mental illness. Can. J. Psychiatr. 2010, 55:752-760.
31. Lembke A. Why doctors prescribe opioids to known opioid abusers. N. Engl. J. Med. 2012, 367:1580-1581.
32. Leong M., Murnion B., Haber P.S. Examination of opioid prescribing in Australia from 1992 to 2007. Intern. Med. J. 2009, 39:676-681.
33. Levy P.S., Lemeshow S. Sampling of Populations 1999, John Wiley & Sons, New York.
34. Martins S.S., Fenton M.C., Keyes K.M., Blanco C., Zhu H., Storr C.L. Mood and anxiety disorders and their association with non-medical prescription opioid use and prescription opioid-use disorder: longitudinal evidence from the National epidemiologic study on alcohol and related conditions. Psychol. Med. 2012, 42:1261-1272.
35. Martins S.S., Keyes K.M., Storr C.L., Zhu H., Chilcoat H.D. Pathways between nonmedical opioid use/dependence and psychiatric disorders: results from the National epidemiologic survey on alcohol and related conditions. Drug Alcohol Depend. 2009, 103:16-24.
36. McCabe S.E., Boyd C.J., Teter C.J. Subtypes of nonmedical prescription drug misuse. Drug Alcohol Depend. 2009, 102:63-70.
37. McCabe S.E., Cranford J.A., Boyd C.J., Teter C.J. Motives, diversion and routes of administration associated with nonmedical use of prescription opioids. Addict. Behav. 2007, 32:562-575.
38. Morley S., Eccleston C., Williams A. Systematic review and meta-analysis of randomized controlled trials of cognitive behaviour therapy and behaviour therapy for chronic pain in adults, excluding headache. Pain 1999, 80:1-13.
39. Novak S.P., Herman-Stahl M., Flannery B., Zimmerman M. Physical pain, common psychiatric and substance use disorders, and the non-medical use of prescription analgesics in the United States. Drug Alcohol Depend. 2009, 100:63-70.
40. Paulozzi L.J. Prescription drug overdoses: a review. J. Saf. Res. 2012, 43:283-289.
41. Paulozzi L.J., Budnitz D.S., Xi Y. Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiol. Drug Saf. 2006, 15:618-627.
42. Seal K.H., Shi Y., Cohen G., Cohen B.E., Maguen S., Krebs E.E., Neylan T.C. Association of mental health disorders with prescription opioids and high-risk opioid use in US veterans of Iraq and Afghanistan. JAMA 2012, 307:940-947.
43. Shah B., Barnswell B.G., Bieler G.S. SUDAAN User's Manual: Software for Analysis of Correlated Data 1995, Research Triangle Institute, Research Triangle Park, NC.
44. Solanki D.R., Koyyalagunta D., Shah R.V., Silverman S.M., Manchikanti L. Monitoring opioid adherence in chronic pain patients: assessment of risk of substance misuse. Pain Physician 2011, 14:E119-E131.
45. Volkow N.D., McLellan T.A., Cotto J.H., Karithanom M., Weiss S.R. Characteristics of opioid prescriptions in 2009. JAMA 2011, 305:1299-1301.
46. Webster L.R., Cochella S., Dasgupta N., Fakata K.L., Fine P.G., Fishman S.M., Grey T., Johnson E.M., Lee L.K., Passik S.D., Peppin J., Porucznik C.A., Ray A., Schnoll S.H., Stieg R.L., Wakeland W. An analysis of the root causes for opioid-related overdose deaths in the United States. Planta Med. 2011, 12(Suppl. 2):S26-S35.